Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, June 14, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 13, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 7, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 15, 2024
[ 12:00 AM ] - WOPRAI
Mon, March 4, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, February 23, 2024
[ 12:00 AM ] - WOPRAI
Mon, February 12, 2024
[ 12:00 AM ] - WOPRAI
Fri, November 10, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 3, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 1, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
Mon, April 3, 2023
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
Thu, January 5, 2023
Tue, November 1, 2022
Etzer Darout Reiterated (TERN) at Buy with Increased Target to $26 on, Sep 16th, 2024
Etzer Darout of BMO Capital, Reiterated "Terns Pharmaceuticals, Inc." (TERN) at Buy with Increased Target from $19 to $26 on, Sep 16th, 2024.
Etzer has made no other calls on TERN in the last 4 months.
There is 1 other peer that has a rating on TERN. Out of the 1 peers that are also analyzing TERN, 0 agree with Etzer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Etzer
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $20 on, Tuesday, September 10th, 2024
Contributing Sources